Publication | Closed Access

Phase I/II Trial of Nonpegylated Liposomal Doxorubicin, Cyclophosphamide, Vincristine, and Prednisone in the Treatment of Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma

Lymphoid NeoplasiaAggressive Non-hodgkinNonpegylated Liposomal DoxorubicinMedicineMalignant Blood DisorderImmunologyPathologyPhase I/ii TrialAdult T-cell Leukemia-lymphomaOncologyRadiation OncologyCancer Research